---
schema_version: "secwatch.filing_event.v1"
accession: "0001737287-23-000060"
form_type: "8-K"
ticker: "ALLO"
cik: "0001737287"
company_name: "Allogene Therapeutics, Inc."
filed_at: "2023-06-14T23:59:59+00:00"
generated_at: "2026-06-14T01:22:08.047964+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CFO Eric Schmidt resigns effective August 2, 2023; search underway

## Summary
- Eric Schmidt, Ph.D., CFO, principal financial and accounting officer, resigned effective August 2, 2023.
- Resignation voluntary to spend more time with family.
- Company has initiated a search for a new CFO.

## SEC filing metadata
- accession: 0001737287-23-000060
- form_type: 8-K
- ticker: ALLO
- cik: 0001737287
- company_name: Allogene Therapeutics, Inc.
- filed_at: 2023-06-14T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737287/000173728723000060/0001737287-23-000060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737287/000173728723000060/allo-20230609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001737287-23-000060
- JSON: https://secwatch.observer/filing/0001737287-23-000060.json
- Plain text: https://secwatch.observer/filing/0001737287-23-000060.txt

## Key facts
- Executive change
  Eric Schmidt resigned as Chief Financial Officer at Allogene Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On June 9, 2023, Eric Schmidt, Ph.D., the Chief Financial Officer, principal financial officer and principal accounting officer of Allogene Therapeutics, Inc. (the “Company”), notified the Company of his decision to resign, effective at the close of business on August 2, 2023, to spend more time with his family.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737287/000173728723000060/0001737287-23-000060-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.